Breast Cancer: Ana's Patient Story
This breast cancer diagnosis at a glance
- Biomarkers
- Hormone-dependent tumor
- Sex
- Female
- Treatment
- surgery, chemotherapy, radiation and hormone therapy
- Outcome
- Care Ongoing
Treatment course, step by step
- Age 45 annual gynecology review found a small lump on ultrasound that mammography had missed
- biopsy confirmed aggressive breast cancer; extension study found only the breast affected
- 1 August lumpectomy/tumorectomy with 3 lymph nodes removed and immediate reconstruction
- 25 August second surgery removed 19 additional lymph nodes, for 22 affected nodes total
- 6 months chemotherapy, first every 3 weeks for 3 months then weekly for remaining months
- 16 radiation sessions
- Tamoxifen plus Zoladex injections every 3 months for 5 years to reduce recurrence risk.
What happened, in summary
Ana was 45 when breast cancer was found during her annual gynecology review. A small lump appeared on ultrasound even though mammography had missed it. Further palpation and biopsy showed breast cancer described to her as aggressive. An extension study found that only the breast was affected, and a multidisciplinary committee planned treatment. Surgery came first. On August 1, Ana had a lumpectomy/tumorectomy with immediate reconstruction and removal of 3 lymph nodes. A second operation on August 25 removed 19 more lymph nodes, bringing the total to 22 affected nodes. Her recovery was supported by her partner and family, although she later wished she had been warned more clearly about arm swelling after lymph node removal. Chemotherapy followed for 6 months: sessions every 3 weeks for the first 3 months, then weekly sessions for the remaining months. Hair loss, insomnia, cramps, foot pain, and slower movement were difficult, but Ana kept asking for help when she needed it. Radiation came next, with 16 sessions and only mild chest redness controlled with cream. Because the tumor was hormone-dependent, her oncologist prescribed Tamoxifen and Zoladex injections every 3 months for 5 years to reduce recurrence risk. Ana continued forward with gratitude and a changed sense of priorities.
Where this story comes from
This is a lay summary of an account first published by MatchTrial Historias Reales. Read the original in full
How we source and attribute stories Accuracy and limitations
These are lay summaries of published cancer stories, for information only. No two cancers behave the same way, and nothing here predicts your own diagnosis or replaces advice from your oncology team. Read the full disclaimer